Table 7.

Multivariate analysis of 5 year survival of the patients diagnosed with plasmacytoma who progressed to myeloma & those with initial diagnosis of Myeloma

Characteristics		Plasmacytoma		Myeloma		P value
		%	95% CI	%	95% CI
Age	>40	54.3%	24.9 – 76.5	31.2%	24.8 – 37.7	0.06
	40-49	34%	19.6 – 48.9	23%	20.5 – 25.6	0.12
	50-59	24.6%	16.5 – 33.5	23.5%	21.9 – 25.1	0.27
	≥60	15.1%	11.4 – 19.3	16.6%	14.8 – 18.4	0.031
Sex	Male	22.2%	17.3 – 27.4	18%	17.2 – 18.9	0.009
	Female	15.9%	11.2 – 21.2	16.9%	16 – 17.8	0.102
Race	White	18.4%	14.6 – 22.4	17.5%	16.8 – 18.3	0.018
	Black	23%	14.1 – 33.3	17.6%	16.2 – 19.2	0.085
	Others	27.1%	9.7 – 48.2	15.4%	14 – 19	0.104
Exposure To Radiotherapy	Without Radiation	13.6%	8.5 – 19.9	18%	17.3 – 18.8	0.062
	With Radiation	21.8%	17.5 – 26.5	15.9%	14.7 – 17.1	<0.05
Radiation Sequence	Adjuvant	22.4%	14.1 – 31.9	18.8%	12.4 – 26.3	0.096
	Neoadjuvant	100%	N/a	0%	N/a	N/a
	Neoadjuvant and adjuvant	0%	N/a	0%	N/a	N/a
Surgical Intervention	No	18.5%	14.5 – 22.8	17.5%	16.8 – 18.1	0.080
	Yes	22.1%	15.4 – 29.7	19.6%	12.7 – 27.7	0.119

N/a Not applicable